A phase I study of zoledronic acid and low-dose cyclophosphamide in recurrent/refractory neuroblastoma: A new approaches to neuroblastoma therapy (NANT) study

  • Heidi V. Russell, Susan G. Groshen, Tasnim Ara, Yves A. DeClerck, Randy Hawkins, Hollie A. Jackson, Heike E. Daldrup-Link, Araz Marachelian, Andrej Skerjanec, Julie R. Park, Howard Katzenstein, Katherine K. Matthay, Susan M. Blaney, Judith G. Villablanca
  • Pediatric Blood & Cancer, November 2010, Wiley
  • DOI: 10.1002/pbc.22821

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1002/pbc.22821

The following have contributed to this page: Heike Daldrup-Link